Butanilicaine
- Level
- Commodity
- Parent
- 51271600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51271604This classification denotes an anesthetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7X3WV51F4N. European Medicines Agency schedules Butanilicaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06003MIG. Butanilicaine generally arises in the molecular formula C13H19CLN2O. The term BUTANILICAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 no. 12 1967, list 7.) BUTANILICAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule butanilicaine under HS 29242995 and SITC 51479. As of Q4 2014, BUTANILICAINE remains the US FDA Preferred Term for this commodity. Butanilicaine bears US NLM identifiers UMLS ID C0054241 and NCI Concept Code C96327. SMILES: CLC1C(NC(=O)CNCCCC)C(CCC1)C.
Same parent
Under 51271600 · 36Activities that produce or sell this
KBLI · 8Inherited from family 51270000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.